Cancer is a leading cause of death and poor quality of life globally. Even though several
strategies are devised to reduce deaths, reduce chronic pain and improve the quality of life …

Radiation therapy (RT) including external beam radiotherapy (EBRT) and internal
radioisotope therapy (RIT) has been widely used for clinical cancer treatment. However …

While liposome-mediated delivery of cytotoxic chemotherapy has been shown to
significantly enhance drug tolerability in patients as compared to the conventional …

NAD (P) H: quinone oxidoreductase 1 (NQO1) is a two-electron reductase responsible for
detoxification of quinones and also bioactivation of certain quinones. It is abnormally …

Diversified nanosystems with tunable physicochemical attributes have emerged as potential
solution to globally devastating cancer by offering novel possibilities for improving the …

Nanoparticle-based anticancer medications were first approved for cancer treatment almost
2 decades ago. Patients benefit from these approaches because of the targeted-drug …

Colorectal cancer (CRC) is the third most common cancer and the fourth most common
deadly cancer worldwide. After treatment with curative intent recurrence rates vary with …

In this issue of ACS Nano, Chen et al. provide in vitro and in vivo evidence for monoclonal
anti-poly (ethylene glycol)(anti-PEG) antibody-triggered, complement terminal complex …

Mitomycin C (MMC) has been using for the treatment of a variety of digestive tract cancers.
However, its nonspecific DNA-alkylating ability usually causes severe side effects, thus …

Colorectal cancer (CRC) is the third most common cancer worldwide. Its poor response to
current treatment options in advanced stages and the need for efficient diagnosis in early …